A groundbreaking trial for TYRA-300, an oral FGFR3 inhibitor, aims to transform treatment for patients with low-grade ...

No one wants to be diagnosed with or go through the physical and psychological toll of cancer. Which is why, sometimes, it's ...

A research team led by Professor Lee Sang-chul of the Department of Urology at Seoul National University Bundang Hospital ...

Sam S. Chang MD, MBA, discusses intravesical mitomycin in low-grade intermediate-risk nonmuscle-invasive bladder cancer vs ...

Boston: TOBY, Inc., a biotech startup advancing non-invasive cancer detection through urine-based volatilomics and Artificial ...

Cancer relapse refers to the reappearance of malignant cells after a period of remission. It can occur months to decades post ...

Carlsbad, California Tuesday, July 1, 2025, 16:00 Hrs [IST] ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

The Trump administration says that it plans to delay and potentially loosen water pollution rules for coal-fired power plants ...

According to the latest study from BCC Research, "Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic ...

Some cancer patients respond better to immunotherapy, radiation or chemotherapy but doctors don’t know why. A new study may ...

Barbara Smith, 78, knows what it’s like to drive frequently to Mobile for care. Her husband, who recently passed away, had ...